IDEAYA Biosciences: Funding, Investors & Team (Sep 2026)
IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy response, and immuno-oncology therapies targeting the tumor micro-environment. IDEAYA, located in South San Francisco and La Jolla, California, has assembled leading scientists and advisors with extensive knowledge and expertise in cancer biology and small molecule drug discovery.
IDEAYA Biosciences has raised $899M across 5 funding rounds on record, the most recent an undisclosed round of $345M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
IDEAYA Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2026.
IDEAYA Biosciences Funding Rounds
IDEAYA Biosciences raised $86.1M in a Post-IPO Equity announced in Jul 2021.
1.2 years later, a Post-IPO Equity of $80.0M was announced in Sep 2022.
1.1 years later, an undisclosed round of $125M was announced in Oct 2023.
9 months later, an undisclosed round of $263M was announced in Jul 2024.
1.9 years later, an undisclosed round of $345M was announced in Jun 2026.
IDEAYA Biosciences Founders and Leadership Team
Contact details for the IDEAYA Biosciences team: 1 of 3 have an email address on file.
Start 14-day free trial →IDEAYA Biosciences Funding Compared to Other Biotechnology Startups
IDEAYA Biosciences' latest round of $345M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IDEAYA Biosciences in Biotechnology and South San Francisco
Companies Similar to IDEAYA Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
IDEAYA Biosciences Funding FAQs
What does IDEAYA Biosciences do?
IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy response, and immuno-oncology therapies targeting the tumor micro-environment. IDEAYA, located in South San Francisco and La Jolla, California, has assembled leading scientists and advisors with extensive knowledge and expertise in cancer biology and small molecule drug discovery.
How much funding has IDEAYA Biosciences raised?
IDEAYA Biosciences has raised $899M across 5 rounds on record. The most recent is an undisclosed round of $345M announced in Jun 2026.
When did IDEAYA Biosciences last raise funding?
IDEAYA Biosciences' most recent funding round on record is an undisclosed round of $345M, announced in Jun 2026.
Who founded IDEAYA Biosciences?
FundedIQ lists Aanan Misra (Founder) at IDEAYA Biosciences.
Who is the CEO of IDEAYA Biosciences?
Yujiro S Hata is listed as CEO at IDEAYA Biosciences.
Where is IDEAYA Biosciences headquartered?
IDEAYA Biosciences is based in South San Francisco, California, United States.
How many employees does IDEAYA Biosciences have?
IDEAYA Biosciences is in the 101-250 employee band.
How does IDEAYA Biosciences' funding compare to other Biotechnology startups?
IDEAYA Biosciences' latest round of $345M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's IDEAYA Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IDEAYA Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.